Clint Narver Partner

In his role at the DOJ, Clint was instrumental in handling and overseeing complex, high-profile investigations and prosecutions involving, among other areas, the manufacture and distribution of drugs and medical devices, research misconduct and clinical trial fraud, health care fraud, consumer and financial fraud, diversion and drug supply chain integrity, pharmacy compounding, and food and dietary supplements. Clint developed particular expertise in handling large-scale grand jury investigations concerning allegations of corporate criminal misconduct. He also developed expertise in criminal and civil enforcement in the health care sector, including as to matters involving the FDCA, the False Claims Act, the Anti-Kickback statute, and various fraud statutes.

Before his tenure at the DOJ, Clint served in various capacities with the United States Food and Drug Administration’s (FDA) Office of the Chief Counsel, where he developed a keen insight into the FDA’s inner workings and regulatory processes. While with the FDA, Clint supported the agency’s Health Care Fraud and Abuse Control (HCFAC) program, worked closely with the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, and the Office of Criminal Investigations, and advised the agency in connection with research misconduct investigations overseen by the HHS Office of Research Integrity. Clint also served as a Special Assistant U.S. Attorney in multiple jurisdictions, handling cases at both the trial and appellate levels.

Clint’s prior government experience and deep understanding of the regulatory landscape make him a valuable asset to clients facing the threat of enforcement action or navigating the complexities of health care industry compliance.